The interaction properties of costimulatory molecules revisited

Immunity

Volumn 17, Issue 2, 2002, Pages 201-210

  Collins, Alison V ^a   Brodie, Douglas W ^b   Gilbert, Robert J C ^c,d   Iaboni, Andrea ^a   Manso Sancho, Raquel ^a   Walse, Björn ^e   Stuart, David I ^c,d   Van Der Merwe, P Anton ^b   Davis, Simon J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Active Biotech Research AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DIMER;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; FEMALE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0036669785     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00362-X     Document Type: Article

References (45)

1. Bachmann M.F., Kohler G., Ecabert B., Mak T.W., Kopf M. Cutting edge. lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous J. Immunol. 163:1999;1128-1131.
2. Bell G.I. Models for the specific adhesion of cells to cells. Science. 200:1978;618-627.
3. Boise L.H., Minn A.J., Noel P.J., June C.H., Accavitti M.A., Lindsten T., Thompson C.B. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity. 3:1995;87-98.
4. Borriello F., Sethna M.P., Boyd S.D., Schweitzer A.N., Tivol E.A., Jacoby D., Strom T.B., Simpson E.M., Freeman G.J., Sharpe A.H. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity. 6:1997;303-313.
5. Brodie D., Collins A.V., Iaboni A., Fennelly J.A., Sparks L.M., Xu X.N., van der Merwe P.A., Davis S.J. LICOS, a primordial costimulatory ligand? Curr. Biol. 10:2000;333-336.
6. Bromley S.K., Iaboni A., Davis S.J., Whitty A., Green J.M., Shaw A.S., Weiss A., Dustin M.L. The immunological synapse and CD28-CD80 interactions. Nat. Immunol. 2:2001;1159-1166.
7. Carreno B.M., Collins M. The B7 family of ligands and its receptors. new pathways for costimulation and inhibition of immune responses Annu. Rev. Immunol. 20:2002;29-53.
8. Davis S.J., Ikemizu S., Wild M.K., van der Merwe P.A. CD2 and the nature of protein interactions mediating cell-cell recognition. Immunol. Rev. 163:1998;217-236.
9. Fukai T., Okada A.A., Sakai J., Kezuka T., Keino H., Usui M., Yagita H., Okumura K., Mizuguchi J. The role of costimulatory molecules B7-1 and B7-2 in mice with experimental autoimmune uveoretinitis. Graefes Arch. Clin. Exp. Ophthalmol. 237:1999;928-933.
10. Greene J.L., Leytze G.M., Emswiler J., Peach R., Bajorath J., Cosand W., Linsley P.S. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions. J. Biol. Chem. 271:1996;26762-26771.
11. Hehner S.P., Hofmann T.G., Dienz O., Droge W., Schmitz M.L. Tyrosine-phosphorylated Vav1 as a point of integration for T-cell receptor- and CD28-mediated activation of JNK, p38, and interleukin-2 transcription. J. Biol. Chem. 275:2000;18160-18171.
12. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I., Kroczek R.A. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 397:1999;263-266.
13. Ikemizu S., Gilbert R.J.C., Fennelly J.A., Collins A.V., Harlos K., Jones E.Y., Stuart D.I., Davis S.J. Structure and dimerization of a soluble form of B7-1. Immunity. 12:2000;51-60.
14. Jenkins M.K. The ups and downs of T cell costimulation. Immunity. 1:1994;443-446.
15. Judge T.A., Wu Z., Zheng X.G., Sharpe A.H., Sayegh M.H., Turka L.A. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. J. Immunol. 162:1999;1947-1951.
16. Kearney E.R., Walunas T.L., Karr R.W., Morton P.A., Loh D.Y., Bluestone J.A., Jenkins M.K. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155:1995;1032-1036.
17. Klug, A. (1969). Point groups and the design of aggregates. In Nobel Symposium 11: Symmetry and Function of Biological Systems at the Macromolecular Level. A. Engstroem and B. Strandberg, eds., pp. 425-436.
18. Kuchroo V.K., Das M.P., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nabavi N., Glimcher L.H. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways. application to autoimmune disease therapy Cell. 80:1995;707-718.
19. Lee K.M., Chuang E., Griffin M., Khattri R., Hong D.K., Zhang W., Straus D., Samelson L.E., Thompson C.B., Bluestone J.A. Molecular basis of T cell inactivation by CTLA-4. Science. 282:1998;2263-2266.
20. Lenschow D.J., Ho S.C., Sattar H., Rhee L., Gray G., Nabavi N., Herold K.C., Bluestone J.A. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1995;1145-1155.
21. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:1996;233-258.
22. Li S., Holdsworth S.R., Tipping P.G. B7.1 and B7.2 co-stimulatory molecules regulate crescentic glomerulonephritis. Eur. J. Immunol. 30:2000;1394-1401.
23. Liang B., Gee R.J., Kashgarian M.J., Sharpe A.H., Mamula M.J. B7 costimulation in the development of lupus. autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-B7.1/B7.2 blocking antibodies J. Immunol. 163:1999;2322-2329.
24. Lindstein T., June C.H., Ledbetter J.A., Stella G., Thompson C.B. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science. 244:1989;339-343.
25. Linsley P.S., Greene J.L., Brady W., Bajorath J., Ledbetter J.A., Peach R. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity. 1:1994;793-801.
26. Linsley P.S., Nadler S.G., Bajorath J., Peach R., Leung H.T., Rogers J., Bradshaw J., Stebbins M., Leytze G., Brady W.et al. Binding stoichiometry of cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulphide-linked homodimer binds two CD86 molecules. J. Biol. Chem. 270:1995;15417-15424.
27. Mandelbrot D.A., McAdam A.J., Sharpe A.H. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J. Exp. Med. 189:1999;435-440.
28. Marengere L.E., Waterhouse P., Duncan G.S., Mittrucker H.W., Feng G.S., Mak T.W. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science. 272:1996;1170-1173.
29. Masteller E.L., Chuang E., Mullen A.C., Reiner S.L., Thompson C.B. Structural analysis of CTLA-4 function in vivo. J. Immunol. 164:2000;5319-5327.
30. Mueller D.L. T cells. a proliferation of costimulatory molecules Curr. Biol. 10:2000;R227-R230.
31. O'Regan M.N., Parsons K.R., Tregaskes C.A., Young J.R. A chicken homologue of the co-stimulating molecule CD80 which binds to mammalian CTLA-4. Immunogenetics. 49:1999;68-71.
32. Read S., Malmstrom V., Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192:2000;295-302.
33. Salomon B., Bluestone J.A. Complexities of CD28/B7. CTLA-4 costimulatory pathways in autoimmunity and transplantation Annu. Rev. Immunol. 19:2001;225-252.
34. Schwartz J.C., Zhang X., Fedorov A.A., Nathenson S.G., Almo S.C. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature. 410:2001;604-608.
35. Shapiro V.S., Truitt K.E., Imboden J.B., Weiss A. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol. Cell. Biol. 17:1997;4051-4058.
36. Sharpe A.H., Freeman G.J. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:2002;116-126.
37. Stamper C.C., Zhang Y., Tobin J.F., Erbe D.V., Ikemizu S., Davis S.J., Stahl M.L., Seehra J., Somers W.S., Mosyak L. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature. 410:2001;608-611.
38. Takahashi T., Tagami T., Yamazaki S., Uede T., Shimizu J., Sakaguchi N., Mak T.W., Sakaguchi S. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192:2000;303-310.
39. van der Merwe P.A., Barclay A.N., Mason D.W., Davies E.A., Morgan B.P., Tone M., Krishnam A.K., Ianelli C., Davis S.J. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry. 33:1994;10149-10160.
40. van der Merwe P.A., McNamee P.N., Davies E.A., Barclay A.N., Davis S.J. Topology of the CD2-CD48 cell-adhesion molecule complex. implications for antigen recognition by T cells Curr. Biol. 5:1995;74-84.
41. van der Merwe P.A., Bodian D.L., Daenke S., Linsley P.S., Davis S.J. B7-1 (CD80) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 185:1997;393-403.
42. Viola A., Schroeder S., Sakakibara Y., Lanzavecchia A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science. 283:1999;680-682.
43. Waterhouse P., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P., Thompson C.B., Griesser H., Mak T.W. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 270:1995;985-988.
44. Willcox B.E., Gao G.F., Wyer J.R., Ladbury J.E., Bell J.I., Jakobsen B.K., van der Merwe P.A. TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity. 10:1999;357-365.
45. Wülfing C., Davis M.M. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. Science. 282:1999;2266-2269.